MDF Fellows report on the current status of their research findings. Featuring: Dr. Ranjan Batra, PhD, University of California San Diego; Dr. Viachaslau Bernat, PhD, Scripps Research Institute Florida; Dr. Melissa Hinman, PhD, University of Oregon; and Dr.
Care Tools Video
Chad Heatwole, MD, MS-CI, of the University of Rochester (presentation); Sarah Howe of the Marigold Foundation (
MDF Fellows Ayal Hendel, PhD, Stanford University (presentation); Suzanne Rzuczek, PhD, Scripps Research Institute of Florida (
Dr. Darren Monckton explains the current research concerning the significance of CTG repeats for persons with DM1.
Dr. Matt Disney and Dr. John Day provide an overview of the DM2 disease mechanism and describe how compounds can be designed as potential therapies for this disease.
Dr. Bruce Wentworth, Ph.D., of Genzyme, presents an overview of ASO treatments, describing in lay language how they are intended to treat DM.
Dr. Darren Monckton describes anticipation, the process by which the disease increases in severity as it is passed from generation to generation, a unique feature of myotonic dystrophy.
Dr. Darren Monckton describes anticipation in myotonic dystrophy, the process by which the disease increases in severity as it is passed from generation to generation.